Russia: a medtech market in transition, but there is growth ahead

under a minute
Read later

The new regulatory system for medical devices in Russia will lead to improvements all around, but industry needs more guidance ay present. So says Vladimir Sokov, a senior partner and head of corporate division at Moscow-based legal firm Pepeliaev Group. In this interview with Ashley Yeo, he describes the new regulatory processes and explains that the market’s flatness at present is more to do with internal government issues than geopolitical unrest.

Отправить статью

Pepeliaev Group’s key projects in 2022
Read more
Aydar Sultanov has joined Pepeliaev Group's team
Read more
A draft law has been submitted to the State Duma based on the outcome of the case of PJSC T Plus which Pepeliaev Group’s lawyers won previously in the Russian Constitutional Court
Read more